Renal transporters in drug development
- PMID: 23140242
- DOI: 10.1146/annurev-pharmtox-011112-140317
Renal transporters in drug development
Abstract
The kidney plays a vital role in the body's defense against potentially toxic xenobiotics and metabolic waste products through elimination pathways. In particular, secretory transporters in the proximal tubule are major determinants of the disposition of xenobiotics, including many prescription drugs. In the past decade, considerable progress has been made in understanding the impact of renal transporters on the disposition of many clinically used drugs. In addition, renal transporters have been implicated as sites for numerous clinically important drug-drug interactions. This review begins with a description of renal drug handling and presents relevant equations for the calculation of renal clearance, including filtration and secretory clearance. In addition, data on the localization, expression, substrates, and inhibitors of renal drug transporters are tabulated. The recent US Food and Drug Administration drug-drug interaction draft guidance as it pertains to the study of renal drug transporters is presented. Renal drug elimination in special populations and transporter splicing variants are also described.
Similar articles
-
The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates.Can J Clin Pharmacol. 2003 Spring;10(1):17-23. Can J Clin Pharmacol. 2003. PMID: 12687033 Review.
-
Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state.Expert Opin Drug Metab Toxicol. 2010 Aug;6(8):939-52. doi: 10.1517/17425255.2010.482930. Expert Opin Drug Metab Toxicol. 2010. PMID: 20433402 Review.
-
Transporters and renal drug elimination.Annu Rev Pharmacol Toxicol. 2004;44:137-66. doi: 10.1146/annurev.pharmtox.44.101802.121856. Annu Rev Pharmacol Toxicol. 2004. PMID: 14744242 Review.
-
Organic anion transporters and their implications in pharmacotherapy.Pharmacol Rev. 2012 Jul;64(3):421-49. doi: 10.1124/pr.111.004614. Epub 2012 Mar 28. Pharmacol Rev. 2012. PMID: 22457399 Review.
-
Renal drug transport: a review.Pharmacotherapy. 1996 Nov-Dec;16(6):971-85. Pharmacotherapy. 1996. PMID: 8947968 Review.
Cited by
-
Ultrasound-Assisted Extraction of Atractylodes chinensis (DC.) Koidz. Polysaccharides and the Synergistic Antigastric Cancer Effect in Combination with Oxaliplatin.ACS Omega. 2024 Apr 14;9(16):18375-18384. doi: 10.1021/acsomega.4c00364. eCollection 2024 Apr 23. ACS Omega. 2024. PMID: 38680328 Free PMC article.
-
Use of a Double-Transfected System to Predict hOCT2/hMATE1-Mediated Renal Drug-Drug Interactions.Drug Metab Dispos. 2024 Mar 13;52(4):296-304. doi: 10.1124/dmd.123.001567. Drug Metab Dispos. 2024. PMID: 38326034
-
Maximum likelihood estimation of renal transporter ontogeny profiles for pediatric PBPK modeling.CPT Pharmacometrics Syst Pharmacol. 2024 Apr;13(4):576-588. doi: 10.1002/psp4.13102. Epub 2024 Jan 10. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38156758 Free PMC article.
-
Effect of Cimetidine on Metformin Pharmacokinetics and Endogenous Metabolite Levels in Rats.Drug Metab Dispos. 2024 Jan 9;52(2):86-94. doi: 10.1124/dmd.123.001470. Drug Metab Dispos. 2024. PMID: 38049999
-
Albumin-bound kynurenic acid is an appropriate endogenous biomarker for assessment of the renal tubular OATs-MRP4 channel.J Pharm Anal. 2023 Oct;13(10):1205-1220. doi: 10.1016/j.jpha.2023.05.007. Epub 2023 May 15. J Pharm Anal. 2023. PMID: 38024860 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
